181 related articles for article (PubMed ID: 25000353)
1. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
Chumpitazi BP; Fishman SJ; Nurko S
Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
[TBL] [Abstract][Full Text] [Related]
3. Neurostimulation-guided Anal Intrasphincteric Botulinum Toxin Injection in Children With Hirschsprung Disease.
Louis-Borrione C; Faure A; Garnier S; Guys JM; Merrot T; Héry G; Dariel A
J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):527-532. PubMed ID: 30444834
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.
Wester T; Granström AL
Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis.
Roorda D; Abeln ZA; Oosterlaan J; van Heurn LW; Derikx JP
World J Gastroenterol; 2019 Jul; 25(25):3268-3280. PubMed ID: 31333317
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
[TBL] [Abstract][Full Text] [Related]
7. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease.
Patrus B; Nasr A; Langer JC; Gerstle JT
J Pediatr Surg; 2011 Jan; 46(1):184-7. PubMed ID: 21238663
[TBL] [Abstract][Full Text] [Related]
8. Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children.
Greer T; Abbott J; Breytenbach W; McGuane D; Barker A; Khosa J; Samnakay N
J Pediatr Urol; 2016 Apr; 12(2):94.e1-6. PubMed ID: 26472538
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
[TBL] [Abstract][Full Text] [Related]
10. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.
Koivusalo AI; Pakarinen MP; Rintala RJ
Pediatr Surg Int; 2009 Oct; 25(10):873-6. PubMed ID: 19662428
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
Minkes RK; Langer JC
J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
[TBL] [Abstract][Full Text] [Related]
12. Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.
Hosseini SM; Foroutan HR; Bahador A; Khosravi MB; Geramizadeh B; Sabet B; Zeraatian S; Razmi T; Banani SJ
Indian J Gastroenterol; 2008; 27(3):99-102. PubMed ID: 18787278
[TBL] [Abstract][Full Text] [Related]
13. Transanal rectal mucosectomy and partial internal anal sphincterectomy for Hirschsprung's disease.
Zhang JS; Li L; Hou WY; Liu SL; Diao M; Zhang J; Ming AX; Cheng W
J Pediatr Surg; 2014 May; 49(5):831-4. PubMed ID: 24851780
[TBL] [Abstract][Full Text] [Related]
14. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
[TBL] [Abstract][Full Text] [Related]
15. Intrasphincteric Botox injections in Hirschsprung's disease: indications and outcome in 64 procedures over a ten-year period.
Pini Prato A; Faticato MG; Mazzola C; Arrigo S; Mattioli G; Arnoldi R; Mosconi M
Minerva Pediatr (Torino); 2023 Aug; 75(4):482-489. PubMed ID: 30419742
[TBL] [Abstract][Full Text] [Related]
16. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
Roorda D; Oosterlaan J; van Heurn E; Derikx J
J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128
[TBL] [Abstract][Full Text] [Related]
17. The problematic Soave cuff in Hirschsprung disease: manifestations and treatment.
Dickie BH; Webb KM; Eradi B; Levitt MA
J Pediatr Surg; 2014 Jan; 49(1):77-80; discussion 80-1. PubMed ID: 24439585
[TBL] [Abstract][Full Text] [Related]
18. Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding.
't Hoen LA; van den Hoek J; Wolffenbuttel KP; van der Toorn F; Scheepe JR
J Pediatr Urol; 2015 Jun; 11(3):119.e1-6. PubMed ID: 25794865
[TBL] [Abstract][Full Text] [Related]
19. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin.
Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655
[TBL] [Abstract][Full Text] [Related]
20. Are routine dilatations necessary post pull-through surgery for Hirschsprung disease?
Aworanti O; Hung J; McDowell D; Martin I; Quinn F
Eur J Pediatr Surg; 2013 Oct; 23(5):383-8. PubMed ID: 23444066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
